China Pharma Holdings, Inc. (CPHI) financial statements (2021 and earlier)
Company profile
| Business Address |
2ND FLOOR, NO. 17, JINPAN ROAD HAINAN PROVINCE, 570216 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 1 | 1 | 2 | 3 | 6 | 6 | ||
| Cash and cash equivalents | 1 | 1 | 2 | 3 | 6 | 6 | ||
| Receivables | 1 | 1 | 2 | (16) | 6 | (44) | ||
| Inventory, net of allowances, customer advances and progress billings | 4 | 5 | 6 | 7 | 10 | 15 | ||
| Inventory | 4 | 5 | 6 | 7 | 10 | 15 | ||
| Prepaid expense | 0 | 0 | 0 | 0 | 0 | |||
| Advances on inventory purchases | 42 | |||||||
| Other undisclosed current assets | 0 | 1 | 1 | 23 | 3 | 24 | ||
| Total current assets: | 6 | 9 | 12 | 18 | 25 | 43 | ||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 16 | 19 | 24 | 25 | 29 | 34 | ||
| Intangible assets, net (including goodwill) | 0 | 0 | 0 | 1 | 1 | 1 | ||
| Intangible assets, net (excluding goodwill) | 0 | 0 | 0 | 1 | 1 | 1 | ||
| Other undisclosed noncurrent assets | 17 | 24 | 35 | 42 | 42 | |||
| Total noncurrent assets: | 17 | 37 | 48 | 61 | 72 | 78 | ||
| TOTAL ASSETS: | 22 | 45 | 60 | 79 | 97 | 121 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 5 | 4 | 4 | 6 | 5 | 4 | ||
| Accounts payable | 5 | 4 | 4 | 6 | 5 | 4 | ||
| Accrued liabilities | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Debt | 2 | 2 | 2 | 1 | 6 | 16 | ||
| Due to related parties | 2 | 2 | 1 | 1 | 1 | 1 | ||
| Customer advances and deposits | ✕ | ✕ | 1 | 1 | 1 | 2 | ||
| Other undisclosed current liabilities | 1 | 2 | 1 | 1 | (10) | |||
| Total current liabilities: | 10 | 10 | 9 | 10 | 13 | 14 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 2 | 4 | 7 | |||||
| Long-term debt, excluding current maturities | 2 | 4 | 7 | |||||
| Operating lease, liability | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 1 | 1 | 0 | 0 | ||||
| Deferred tax liabilities, net | ✕ | 1 | 1 | 0 | 0 | |||
| Other undisclosed noncurrent liabilities | 1 | 9 | 11 | 14 | ||||
| Total noncurrent liabilities: | 3 | 5 | 8 | 9 | 12 | 14 | ||
| Total liabilities: | 13 | 15 | 17 | 20 | 25 | 28 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | 9 | 30 | 43 | 59 | 73 | 93 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 24 | 24 | 24 | 24 | 24 | 24 | ||
| Accumulated other comprehensive income | 12 | 12 | 14 | |||||
| Retained earnings (accumulated deficit) | (26) | (5) | 5 | 25 | 34 | 49 | ||
| Other undisclosed stockholders' equity attributable to parent | 11 | 15 | 20 | |||||
| Total stockholders' equity: | 9 | 30 | 43 | 59 | 73 | 93 | ||
| TOTAL LIABILITIES AND EQUITY: | 22 | 45 | 60 | 79 | 97 | 121 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 11 | 12 | 13 | 16 | 20 | 22 | |
| Cost of revenue | (9) | (10) | (11) | (12) | (16) | (17) | |
| Cost of goods and services sold | (0) | (1) | (0) | (3) | (2) | ||
| Other undisclosed gross profit | (2) | ||||||
| Gross profit: | 1 | 2 | 2 | 3 | 5 | 3 | |
| Operating expenses | (22) | (12) | (21) | (12) | (17) | (41) | |
| Other operating income (expense), net (Other Expenses) | 1 | (1) | 1 | ||||
| Other undisclosed operating loss | (0) | (0) | (1) | ||||
| Operating loss: | (20) | (10) | (19) | (8) | (14) | (39) | |
| Nonoperating income (expense) | (0) | (0) | (0) | 0 | 0 | 0 | |
| Investment income, nonoperating | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest and debt expense | (0) | (0) | (1) | 1 | (1) | 1 | |
| Loss from continuing operations before equity method investments, income taxes: | (21) | (11) | (20) | (7) | (15) | (38) | |
| Other undisclosed income (loss) from continuing operations before income taxes | 0 | 0 | 1 | (2) | (2) | ||
| Loss from continuing operations before income taxes: | (21) | (11) | (19) | (9) | (15) | (39) | |
| Income tax expense (benefit) | 0 | (0) | (0) | 0 | 0 | ||
| Loss before gain (loss) on sale of properties: | (21) | (11) | (19) | (9) | (15) | (39) | |
| Other undisclosed net loss | (0) | ||||||
| Net loss: | (21) | (11) | (19) | (9) | (15) | (40) | |
| Other undisclosed net loss attributable to parent | (0) | ||||||
| Net loss available to common stockholders, diluted: | (21) | (11) | (19) | (9) | (15) | (40) | |
Comprehensive Income ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (21) | (11) | (19) | (9) | (15) | (40) | |
| Other comprehensive loss | (16) | (14) | (20) | (40) | |||
| Comprehensive loss: | (21) | (11) | (35) | (23) | (35) | (80) | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (0) | (2) | |||||
| Comprehensive loss, net of tax, attributable to parent: | (21) | (13) | (35) | (23) | (35) | (80) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.